Corporate-sponsored education will focus on blood availability and the intercept blood system

Oct. 13, 2022
Science and Innovation Forum.

Inventory management for platelet components and of fibrinogen sources (cryoprecipitated antihemophilic factor) can be challenging given their short shelf-life.

An upcoming Science and Innovation Forum presented by Cerus Corporation will describe how pathogen-reduced platelets (Intercept Platelets) and pathogen-reduced cryoprecipitated fibrinogen complex (Intercept Fibrinogen Complex) may improve blood availability for patients in need.

This program will take place at 2 p.m. ET on Wednesday, Nov. 30. Registration is complimentary but required to attend.

AABB release

ID 36875902 © Funniefarm5 | Dreamstime.com
dreamstime_xxl_36875902
ID 360584366 © Yuri Arcurs | Dreamstime.com
dreamstime_xxl_360584366
ID 325291561 © Anulak Ac | Dreamstime.com
dreamstime_xxl_325291561
ID 147811957 © Andrey Popov | Dreamstime.com
dreamstime_xxl_147811957
ID 343039503 © Ahmadrizal7373 | Dreamstime.com
dreamstime_xxl_343039503